Evidence map›Paper›PMID 26738985›Full record

Trial reportScientific reports2016

Apoptosis-related microRNA changes in the right atrium induced by remote ischemic perconditioning during valve replacement surgery.

Qinghua Hu, Wanjun Luo, Lingjin Huang, Rimao Huang, Ri Chen

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. AJournal of cellular and molecular medicine · 2020
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Cardioprotection by remote ischemic conditioning and its signal transduction.Pflugers Archiv : European journal of physiology · 2017
    Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qinghua HuDepartment of cardiovascular surgery, Xiangya Hospital, Central-South University, Changsha, Hunan, China, 410078.
Wanjun LuoDepartment of cardiovascular surgery, Xiangya Hospital, Central-South University, Changsha, Hunan, China, 410078.
Lingjin HuangDepartment of cardiovascular surgery, Xiangya Hospital, Central-South University, Changsha, Hunan, China, 410078.
Rimao HuangDepartment of cardiovascular surgery, Xiangya Hospital, Central-South University, Changsha, Hunan, China, 410078.
Ri ChenDepartment of cardiovascular surgery, Xiangya Hospital, Central-South University, Changsha, Hunan, China, 410078.
Xiangya Hospital Central South University · CNCentral South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously found that remote ischemic perconditioning (RIPerc) was effective in attenuating myocardial injury during cardiac surgery. Given that microRNAs (miRs) act as an important player in ischemic/reperfusion (I/R) injury and apoptosis, this study aimed to investigate whether RIPerc reduces apoptosis in atrial myocardium and which apoptosis-related miRs are involved during valve replacement surgery. Here, we demonstrated that RIPerc inhibited apoptosis in atrial myocardium during cardiac ischemia and that 17 miRs showed at least a 1.5-fold change in expression after ischemia. Of the 17 miRs, 9 miRs, including miR-1, miR-21, miR-24, and miR-195, which are related to apoptosis, exhibited different expression patterns in the RIPerc group compared with the control. Using qRT-PCR and Western blotting, we demonstrated that miR-1 and miR-195 were downregulated and that their common putative target gene Bcl-2 was upregulated in the RIPerc group. However, the differences in miR-21 and miR-24 expression, together with programmed cell death 4 (PDCD4), which is the target gene of miR-21, were not significant. These findings provide some insight into the role of miRs in the cardioprotective effects induced by RIPerc.

Indexed as

ApoptosisAdultApoptosis Regulatory ProteinsDown-RegulationFemaleHeart AtriaHeart Valve DiseasesHeart Valve Prosthesis ImplantationHumansIschemic Preconditioning, MyocardialMaleMicroRNAsMiddle AgedMyocardiumRNA InterferenceTreatment OutcomeApoptosis Regulatory ProteinsMicroRNAs

Identifiers

PMID26738985
PMCPMC4704063
OpenAlexW2227294482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.